Revision as of 09:53, 18 April 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit | Revision as of 14:26, 19 September 2011 edit undoAnypodetos (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers39,350 edits Stub template; ATC code; grammarNext edit → | ||
Line 8: | Line 8: | ||
| component2 = Polymyxin | | component2 = Polymyxin | ||
| class2 = ] | | class2 = ] | ||
| ATC_prefix = | | ATC_prefix = S01 | ||
| ATC_suffix = | | ATC_suffix = AA30 | ||
| ATC_supplemental = | | ATC_supplemental = | ||
| PubChem = 24848162 | | PubChem = 24848162 | ||
Line 26: | Line 26: | ||
| legal_status = | | legal_status = | ||
| dependency_liability = | | dependency_liability = | ||
| routes_of_administration = ] | | routes_of_administration = ]s | ||
}} | }} | ||
The ] combination ''']/]''' (], trade name '''Polytrim''') is an ] solution for topical ] use in the treatment of ] ] ] and ]. | The ] combination ''']/]''' (], trade name '''Polytrim''') is an ] solution for topical ] use in the treatment of ] ] ] and ]. | ||
Line 37: | Line 37: | ||
] | ] | ||
] | ] | ||
{{pharma-stub}} |
Revision as of 14:26, 19 September 2011
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Trimethoprim/polymyxin B" – news · newspapers · books · scholar · JSTOR (February 2011) (Learn how and when to remove this message) |
Combination of | |
---|---|
Trimethoprim | Nucleic acid inhibitor antibiotic |
Polymyxin | Cell envelope antibiotic |
Clinical data | |
Routes of administration | Eye drops |
ATC code | |
Identifiers | |
PubChem CID | |
CompTox Dashboard (EPA) | |
(verify) |
The drug combination trimethoprim/polymyxin (INNs, trade name Polytrim) is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |